HK1154502A1 - Preparation method of drug loaded emulsion - Google Patents

Preparation method of drug loaded emulsion

Info

Publication number
HK1154502A1
HK1154502A1 HK11108761.7A HK11108761A HK1154502A1 HK 1154502 A1 HK1154502 A1 HK 1154502A1 HK 11108761 A HK11108761 A HK 11108761A HK 1154502 A1 HK1154502 A1 HK 1154502A1
Authority
HK
Hong Kong
Prior art keywords
preparation
drug loaded
loaded emulsion
emulsion
drug
Prior art date
Application number
HK11108761.7A
Other languages
English (en)
Chinese (zh)
Inventor
仝新勇
王海鳳
力 于
亮 陳
遠 石
Original Assignee
江蘇恒瑞醫藥股份有限公司
江蘇省連雲港市經濟技術開發區
上海恒瑞醫藥有限公司
上海市閔行區文井路
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 江蘇恒瑞醫藥股份有限公司, 江蘇省連雲港市經濟技術開發區, 上海恒瑞醫藥有限公司, 上海市閔行區文井路 filed Critical 江蘇恒瑞醫藥股份有限公司
Publication of HK1154502A1 publication Critical patent/HK1154502A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK11108761.7A 2009-06-04 2011-08-19 Preparation method of drug loaded emulsion HK1154502A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2009100525352A CN101904814A (zh) 2009-06-04 2009-06-04 制备载药乳剂的方法
PCT/CN2010/073500 WO2010139278A1 (zh) 2009-06-04 2010-06-03 制备载药乳剂的方法

Publications (1)

Publication Number Publication Date
HK1154502A1 true HK1154502A1 (en) 2012-04-27

Family

ID=43260505

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11108761.7A HK1154502A1 (en) 2009-06-04 2011-08-19 Preparation method of drug loaded emulsion

Country Status (11)

Country Link
US (1) US20120177699A1 (xx)
EP (1) EP2438909A1 (xx)
JP (1) JP2012528804A (xx)
KR (1) KR20120027298A (xx)
CN (2) CN101904814A (xx)
AU (1) AU2010256130A1 (xx)
BR (1) BRPI1010950A2 (xx)
CA (1) CA2762918A1 (xx)
HK (1) HK1154502A1 (xx)
MX (1) MX2011012884A (xx)
WO (1) WO2010139278A1 (xx)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX340897B (es) * 2007-10-02 2016-07-29 Theranos Inc Dispositivos modulares de punto de cuidado y usos de los mismos.
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
CN102600077B (zh) * 2012-03-29 2013-06-05 江苏豪森药业股份有限公司 吉西他滨或其盐纳米乳剂注射液及其制备方法
JP6121796B2 (ja) * 2012-05-23 2017-04-26 キユーピー株式会社 脂肪乳剤および医薬品組成物中の非ステロイド性抗炎症薬の含有量を高める方法
CN102793730B (zh) * 2012-08-31 2013-11-06 山西普德药业股份有限公司 银杏达莫的药物组合物及其制备方法
CN102988285B (zh) * 2012-12-13 2014-02-19 哈药集团技术中心 一种多西他赛注射液组合物及其制备方法
GB2511028A (en) * 2012-12-18 2014-08-27 Univ Manchester Metropolitan Nano emulsions, methods of forming the same and uses thereof
KR101586790B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
CN103961314A (zh) * 2013-01-24 2014-08-06 上海医药工业研究院 一种稳定的麻醉乳剂
KR101498274B1 (ko) * 2013-01-30 2015-03-11 재단법인 전남생물산업진흥원 편백 정유 에멀젼의 제조방법
CN104706587A (zh) * 2013-12-16 2015-06-17 天津迈迪瑞康生物医药科技有限公司 一种依托咪酯脂肪乳浓缩液、其制备方法及用途
CN103750050B (zh) * 2014-01-21 2016-07-06 武汉轻工大学 棕榈油纳米乳液的制备方法
SG11201701292XA (en) * 2014-08-27 2017-03-30 Abbvie Inc Topical formulation
CN105816465A (zh) * 2015-01-08 2016-08-03 辽宁医联新药研究所 丙泊酚与地西泮药物组合物及其应用
CN104606135A (zh) * 2015-01-22 2015-05-13 李宏 一种含多西他赛的组合物及其制备方法
CN104644554B (zh) * 2015-03-05 2018-03-16 北京蓝丹医药科技有限公司 一种依托咪酯药物组合物及其制备方法
CN105055310B (zh) * 2015-08-30 2018-03-09 四川百利药业有限责任公司 一种注射用依托咪酯组合物及其制备方法
US11365198B2 (en) 2015-10-16 2022-06-21 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US11512092B2 (en) 2015-10-16 2022-11-29 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
EP3362455A1 (en) 2015-10-16 2018-08-22 AbbVie Inc. PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
US11780848B2 (en) 2015-10-16 2023-10-10 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof
US10550126B2 (en) 2015-10-16 2020-02-04 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US11524964B2 (en) 2015-10-16 2022-12-13 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US10092553B2 (en) 2016-04-13 2018-10-09 Nortic Holdings Inc. Stable nimodipine parenteral formulation
HRP20221100T1 (hr) * 2016-04-13 2022-11-25 Acasti Pharma U.S., Inc. Stabilna parenteralna formulacija nimopidina
CN110496101A (zh) * 2016-06-24 2019-11-26 广东双骏生物科技有限公司 一种稳定型维生素k2亚微乳及其制备方法
CN106070660A (zh) * 2016-07-09 2016-11-09 东北农业大学 一种水酶法提取大豆纳米乳状液的方法
WO2018064350A1 (en) * 2016-09-30 2018-04-05 Eriochem Usa, Llc Apo-e modified lipid nanoparticles for drug delivery to targeted tissues and therapeutic methods
CN108096408A (zh) * 2016-11-17 2018-06-01 中国科学院大连化学物理研究所 一种鼻用喷雾剂及其制备和应用
KR20190121752A (ko) * 2017-03-06 2019-10-28 마루이시세이야쿠가부시키가이샤 국소마취약 함유 산성 에멀션 조성물
WO2018165581A1 (en) 2017-03-09 2018-09-13 Abbvie Inc. Methods of treating crohn's disease and ulcerative colitis
US11564922B2 (en) 2017-03-09 2023-01-31 Abbvie Inc. Methods of treating crohn's disease and ulcerative colitis
JP2021513995A (ja) * 2018-02-22 2021-06-03 ノーティック ホールディングス インコーポレイテッド 安定したニモジピン非経口製剤
US20190307892A1 (en) * 2018-04-04 2019-10-10 Eriochem Usa, Llc Targeted drug delivery and therapeutic methods using apo-e modified lipid nanoparticles
CN108743952B (zh) * 2018-06-11 2021-08-31 西安力邦医药科技有限责任公司 局部麻醉药的磷脂-混溶剂-油缓释递药系统组方与制备方法
CN108553414A (zh) * 2018-06-19 2018-09-21 吉林百年汉克制药有限公司 一种人参糖肽注射液药物组合物及其制备方法和应用
US20210338649A1 (en) * 2018-09-08 2021-11-04 Jiangsu Jiuxu Haitian Pharmaceutical Co., Ltd. Nimodipine injection composition and preparation method therefor
CN111840553A (zh) * 2019-04-15 2020-10-30 湖州依诺唯新药物制剂有限公司 脂性药物制剂及其应用
CN111904933B (zh) * 2019-05-08 2023-06-13 北京化工大学 一种透明水分散型达沙替尼纳米乳及其制备方法
CN114099433A (zh) * 2020-09-01 2022-03-01 宜昌人福药业有限责任公司 挥发性麻醉药注射用脂肪乳的制备方法及其组合物
CN114668720A (zh) * 2020-12-24 2022-06-28 远大生命科学(武汉)有限公司 一种依托咪酯乳状注射液及其制备方法
CN112933043B (zh) * 2021-02-24 2022-07-12 石家庄四药有限公司 一种盐酸阿比多尔注射乳剂及其制备方法
US11992483B2 (en) 2021-03-31 2024-05-28 Cali Biosciences Us, Llc Emulsions for local anesthetics
CN113425683B (zh) * 2021-08-19 2022-09-20 谢彩华 一种三氮脒缓释注射剂及其制备方法
CN114307708B (zh) * 2022-01-07 2023-07-18 苏州大学 一种连续制备载药纳米乳的方法
CN115350156B (zh) * 2022-08-26 2023-11-28 丽珠集团丽珠制药厂 一种克拉霉素片及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10036871A1 (de) 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
CN1274304C (zh) 2002-03-25 2006-09-13 徐州颐华医药科技有限公司 依托咪酯脂肪乳注射剂的制备方法
CN1278682C (zh) 2003-12-04 2006-10-11 东南大学 天然维生素e脂质纳米粒悬浮液
CN100386078C (zh) 2004-07-08 2008-05-07 上海医药工业研究院 尼莫地平乳注射液及制备方法
CN1289078C (zh) 2004-11-12 2006-12-13 重庆华立药业股份有限公司 一种新的静脉注射用紫杉醇乳剂及其制备方法
CN100462076C (zh) 2005-01-20 2009-02-18 江苏正大天晴药业股份有限公司 供静脉用长春花生物碱的稳定水包油乳剂及其制备方法
CN100486587C (zh) 2005-10-14 2009-05-13 刘玉辉 克拉霉素的脂质微球注射液及其制备方法
CN100375621C (zh) 2005-11-04 2008-03-19 唐星 长春瑞滨脂质微球注射液及其制备方法
CN100394918C (zh) 2006-05-18 2008-06-18 西安力邦制药有限公司 鞘磷脂异丙酚脂肪乳制剂及其制备方法
CN1973826A (zh) * 2006-12-18 2007-06-06 沈阳药科大学 含有依托泊苷的脂质微球注射液及其制备方法
CN101288642B (zh) * 2007-11-07 2011-04-27 天津天士力集团有限公司 一种紫杉烷类药物静脉给药制剂及其制备方法

Also Published As

Publication number Publication date
WO2010139278A1 (zh) 2010-12-09
US20120177699A1 (en) 2012-07-12
EP2438909A1 (en) 2012-04-11
BRPI1010950A2 (pt) 2018-03-06
CN102159188B (zh) 2014-07-09
CN101904814A (zh) 2010-12-08
CN102159188A (zh) 2011-08-17
JP2012528804A (ja) 2012-11-15
MX2011012884A (es) 2012-01-12
KR20120027298A (ko) 2012-03-21
CA2762918A1 (en) 2010-12-09
AU2010256130A1 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
HK1154502A1 (en) Preparation method of drug loaded emulsion
EP2579807A4 (en) METHOD FOR FORMING A SPECIFIC IMPLANT OF A PATIENT
EP2623100A4 (en) PREPARATION FOR IMPROVING THE SOLUBILITY OF A POOR SOLVENT MEDICAMENT
HUE056843T2 (hu) Gyógyszerek infúziója
EP2607482A4 (en) SOLUTION FOR RNA EXTRACTION
HK1177583A1 (zh) 用於掩蓋姜黃素風味的方法
GB201018147D0 (en) Method of treatment
EP2648519A4 (en) NEW POLYMORPH OF NILOTINIB HYDROCHLORIDE
ZA201303813B (en) Methods of treatment using lipid compounds
EP2745235A4 (en) METHOD FOR REPOSITIONING MEDICATION
GB201003920D0 (en) Method of treatment
ZA201109514B (en) Method of drug delivery
SI2757878T1 (sl) Postopek za pripravo in nadgradnjo podkev
IL231505B (en) Pharmaceutical preparation and method for its production
IL222360A0 (en) Method of vaccination
HK1174587A1 (zh) 形成錨固器的方法
EP2734513A4 (en) INTERMEDIATE PRODUCT OF STATIN MEDICINES AND THEIR MANUFACTURE
EP2767533A4 (en) BUTYLPHTHALID DERIVATIVE, METHOD OF MANUFACTURING THEREOF AND USE THEREOF
IL213955A (en) Method for improved biological activity of pharmaceutical preparations
EP2358693A4 (en) PREPARATION OF DOCETAXEL
EP2548881A4 (en) PROCESS FOR THE PREPARATION OF DROSPIRENONE
EP2729094A4 (en) METHOD OF USE OF MEDICAL IMPLANTS
EP2404891A4 (en) PROCESS FOR THE PREPARATION OF ACYLBENZENES
EP2585103A4 (en) METHOD OF TREATMENT
EP2578568A4 (en) PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED FLUOROPYRROLIDINE DERIVATIVES

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190601